Home・Aktien・GE HealthCare Technologies

GE HealthCare Technologies

Open

BrancheGesundheitswesen

74.04 -0.76

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

73.95

Max

75.61

Schlüsselkennzahlen
By Trading Economics
Einkommen	163M 574M
Verkäufe	164M 5.3B
KGV Branchendurchschnitt	16.988 57.371
EPS	1.13
Dividendenrendite	0.19
Gewinnspanne	10.84
Angestellte	54,000
EBITDA	198M 953M

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+5.96% upside

Dividenden
By Acuity
Dividendenrendite Branchendurchschnitt	0.19% 2.23%
Nächstes Ergebnis	28. Okt. 2026
Nächste Dividendenausschüttung	13. Nov. 2026
Nächstes Ex-Dividendendatum	23. Okt. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	5.1B 33B
Vorheriger Eröffnungskurs	74.8
Vorheriger Schlusskurs	74.04

Nachrichtenstimmung

By Acuity

93%

6 / 340 Ranking in Healthcare

GE HealthCare Technologies Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

19. Aug. 2026, 20:06 UTC

News

GE Healthcare Technologies appointed William Grogan as CFO, effective September 2026. BTIG reiterated its Buy rating with a $79 price target. Shares are higher since Tuesday's close.

18. Aug. 2026, 23:51 UTC

GE Healthcare Technologies Inc. shares are higher in after-market trading, reaching above Tuesday's close despite elevated bond yields and ongoing inflation concerns.

17. Aug. 2026, 23:11 UTC

GE Healthcare Technologies shares are higher in after-market trading, reaching a notable increase while remaining above its 20-day moving average. No specific news was identified.

14. Aug. 2026, 19:46 UTC

GE Healthcare Technologies is trading roughly flat, with no specific news identified. Shares peaked earlier but have since settled back down.

13. Aug. 2026, 23:46 UTC

GE Healthcare Technologies shares declined in after-market trading, reflecting a slight drop since Thursday's close. The stock remained above its 20-day moving average.

12. Aug. 2026, 23:26 UTC

News

Trian Fund Management increased its stake in GE Healthcare Technologies to 3.1 million shares, contributing to a modest rise in after-market hours.

11. Aug. 2026, 20:06 UTC

GE Healthcare Technologies shares are lower today amid broader market declines. The stock remains above its 20-day moving average despite earlier gains.

10. Aug. 2026, 19:16 UTC

GE Healthcare Technologies shares are higher today, reflecting gains since Friday's close. No specific news was identified to explain the price movement.

7. Aug. 2026, 23:36 UTC

No specific news for GE Healthcare Technologies. The stock traded roughly flat after-market, remaining near the upper end of its one-month range.

6. Aug. 2026, 19:46 UTC

GE Healthcare Technologies remains roughly flat as price fluctuations continue. The stock trades near the upper end of its one-month range and above its moving average.

5. Aug. 2026, 19:56 UTC

News

GE Healthcare reported strong Q2 results with $5.30 billion in revenue and adjusted EPS of $1.13, but shares are trading lower since Tuesday's close.

4. Aug. 2026, 23:41 UTC

Shares of GE Healthcare Technologies are trading higher in after-market hours, reflecting unusual activity and remaining above the 20-day moving average.

3. Aug. 2026, 23:01 UTC

Shares of GE Healthcare Technologies declined after-market, continuing a downward trend since Monday's close amid broader market conditions.

31. Juli 2026, 23:16 UTC

News

Shares of GE Healthcare Technologies are lower in after-market trading following UBS's Neutral rating and a price target increase to $73.

30. Juli 2026, 22:31 UTC

News

GE Healthcare Technologies reported Q2 revenue of $5.30 billion, but shares are trading lower after highlighting challenges in the Patient Care Solutions segment.

29. Juli 2026, 23:21 UTC

GE Healthcare shares are lower in after-market hours, reflecting a decline after briefly recovering earlier in the session. No specific news was identified.

28. Juli 2026, 23:41 UTC

GE Healthcare Technologies Inc. shares are higher in after-market trading, showing volatility with no specific news identified to explain the movement.

27. Juli 2026, 23:16 UTC

GE Healthcare shares are trading higher in after-market hours, reflecting a modest increase since Monday's close amid positive sentiment in European markets.

24. Juli 2026, 20:03 UTC

Event

News

GE Healthcare shares decline as CFO Jay Saccaro steps down amid preliminary Q2 results showing revenue growth to $5.295 billion.

23. Juli 2026, 23:41 UTC

Event

News

GE Healthcare appointed George Newcomb as interim CFO and reported $5.30 billion in second-quarter revenue, with shares higher in after-market trading.

22. Juli 2026, 23:31 UTC

GE Healthcare Technologies shares moved higher in after-market trading, despite earlier fluctuations. Broader market dynamics include rising crude oil prices amid U.S.-Iran tensions.

21. Juli 2026, 23:46 UTC

GE Healthcare shares are higher in after-market hours amid positive market sentiment from recent earnings reports, though they remain below the 20-day moving average.

20. Juli 2026, 16:31 UTC

News

GE Healthcare Technologies has launched MIM Anyware, enhancing remote access to its software portfolio. Shares are trading higher, breaking from a recent upward trend.

Peer-Vergleich

Kursveränderung

GE HealthCare Technologies Prognose

Kursziel

By TipRanks

5.96% Vorteil

12-Monats-Prognose

Durchschnitt 79.07 USD 5.96%

Hoch 92 USD

Tief 70 USD

Basierend auf 14 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für GE HealthCare Technologies – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

14 ratings

Buy

Halten

Sell

Basierend auf 14 Analysten, die in den letzten 3 Monaten Aktienbewertungen für GE HealthCare Technologies – Dist abgegeben haben.

Stimmung

By Acuity

6 / 340 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über GE HealthCare Technologies

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.